Podcasts | Accessible conversations on pharma's hot topics

Skip to main content

Monday 14 July 2025

BlueSky linkedin youtube rss

User account menu

Subscribe

Channels

Content type

Categories

Categories

Sort by

Order

Pharmaphorum menu first category

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
Spotlight on
Events

close

Channels

Content type

Categories

Categories

Sort by

Order

SECTION

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
White Papers
Events

Channels

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight On

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight On

SUB NAVIGATION

Live Coverage
Partner Content
About us
Work for us
Contribute
Contact us
Advertise

Newsletters and Deep Dive digital magazine

Sign up

BlueSky linkedin rss

Sign in

Oncology

pharmaphorum podcast Episode 190a, Greg Piefer

On nuclear medicine and oncology, SHINE Technologies

Greg Piefer, founder and CEO of SHINE Technologies, discusses nuclear medicine and the role of radiopharmaceuticals in oncology.

Digital

pharmaphorum podcast Episode 138 - Eloise McLennan

Unicorns, AI, and the future of health: Highlights from HLTH...

Deep Dive editor Eloise McLennan debriefs on the key themes, hot topics, and hallway conversations that shaped the HLTH event in Amsterdam.

Patients

pharmaphorum podcast Episode 189a, Marc Buyse

On patient-centric treatment decisions and the value of quan...

Marc Buyse, founder of IDDI and One2Treat, and also co-founder of CluePoints, discusses the pressing need for quantitative methodologies.

R&D

pharmaphorum podcast Episode 188a - Novo Nordisk and Veeva

Maximising value by uniting the digital backbone: On a new N...

Novo Nordisk and Veeva have entered into a new partnership for clinical development.

Market Access

pharmaphorum podcast Episode 187a

The changing landscape of drug clinical assessment: Tommy Br...

In a new pharmaphorum podcast, Tommy Bramley, SVP of market access and healthcare consulting at Cencora, discusses Joint Clinical Assessments.

Patients

pharmaphorum podcast Episode 189a, Marc Buyse

On patient-centric treatment decisions and the value of quan...

Marc Buyse, founder of IDDI and One2Treat, and also co-founder of CluePoints, discusses the pressing need for quantitative methodologies.

R&D

pharmaphorum podcast Episode 188a - Novo Nordisk and Veeva

Maximising value by uniting the digital backbone: On a new N...

Novo Nordisk and Veeva have entered into a new partnership for clinical development.

Market Access

pharmaphorum podcast Episode 187a

The changing landscape of drug clinical assessment: Tommy Br...

In a new pharmaphorum podcast, Tommy Bramley, SVP of market access and healthcare consulting at Cencora, discusses Joint Clinical Assessments.

Load more results

Sales & Marketing

Sales & Marketing

pharmaphorum podcast episode 107a

Looking to the future of UK medical device exports

In this second of our festive podcast series, the pharmaphorum podcast welcomed Brandon Medical CEO Keith Jackson and the Association of British HealthTech Industri

Sales & Marketing

pharmaphorum podcast episode 94a

Focussing on finding value in health sciences marketing

In this latest instalment of the pharmaphorum podcast, web editor Nicole Raleigh speaks with life sciences advisor Randall Hein, CEO of Heinsight LLC, and health sciences marketing expert K

Digital

Digital

pharmaphorum podcast Episode 138 - Eloise McLennan

Unicorns, AI, and the future of health: Highlights from HLTH...

Deep Dive editor Eloise McLennan debriefs on the key themes, hot topics, and hallway conversations that shaped the HLTH event in Amsterdam.

Digital

pharmaphorum podcast Episode 176a - Andrew Stelzer, Unlearn.AI

AI in drug development: The real hurdle is implementation

Web editor Nicole Raleigh speaks with Andrew Stelzer, head of business development at Unlearn.AI, about effectively implementing AI.

Market Access

Market Access

pharmaphorum podcast Episode 187a

The changing landscape of drug clinical assessment: Tommy Br...

In a new pharmaphorum podcast, Tommy Bramley, SVP of market access and healthcare consulting at Cencora, discusses Joint Clinical Assessments.

Market Access

pharmaphorum podcast Episode 179a - Cen Zorlular, Er-Kim Pharmaceuticals

EAPs: Market access outside of the US and Western Europe

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Cem Zorlular, CEO of Er-Kim Pharmaceuticals about early access programmes.

Editor's Picks

Update: MSD confirms $10bn takeover deal for Verona Pharma

AbbVie cuts $1.9bn+ deal with IGI for trispecific antibody

UK authority cracks down on weight-loss drug ads

First malaria drug for newborns and young infants cleared

Medical groups sue RFK Jr over COVID-19 policies

Newsletters and Deep Dive
digital magazine

Get in-depth news, opinions, and features on pharma and healthcare sent straight to your inbox

Oncology

Oncology

pharmaphorum podcast Episode 190a, Greg Piefer

On nuclear medicine and oncology, SHINE Technologies

Greg Piefer, founder and CEO of SHINE Technologies, discusses nuclear medicine and the role of radiopharmaceuticals in oncology.

Oncology

pharmaphorum podcast Episode 185a - Dr Stacy Lindborg

IMUNON at ASCO 2025: Changing the micro-tumour environment i...

Oncology

pharmaphorum podcast Episode 184a

Treating primary bone cancer: The potential of listeria-base...

In a new pharmaphorum podcast, Paul Romness, president and CEO of OS Therapies, discusses the company's work in osteosarcoma.

Patients

Patients

pharmaphorum podcast Episode 189a, Marc Buyse

On patient-centric treatment decisions and the value of quan...

Marc Buyse, founder of IDDI and One2Treat, and also co-founder of CluePoints, discusses the pressing need for quantitative methodologies.

Patients

pharmaphorum podcast Episode 180a - Rebecca Catterick

The need for a science-first mindset: The vaccine landscape ...

In a new pharmaphorum podcast, Rebecca Catterick, previously at Sanofi, discusses the decline in vaccination rates.

Patients

pharmaphorum podcast Episode 177a - Rob Abbott, ISPOR

The ins and outs of HEOR – A lever for global health

Web editor Nicole Raleigh speaks with Rob Abbott, CEO and executive director of ISPOR, about the ins and outs and trends of HEOR.

R&D

R&D

pharmaphorum podcast Episode 188a - Novo Nordisk and Veeva

Maximising value by uniting the digital backbone: On a new N...

Novo Nordisk and Veeva have entered into a new partnership for clinical development.

R&D

Lady listening via ear pods to a podcast interview that features Melissa Sharman

Precision, speed, impact: Evolving mass spectrometry for med...

MOBILion's Melissa Sherman explores the evolving role of mass spectrometry in drug discovery, complex molecule analysis, and medical research.

R&D

Citylabs 4.0

Sponsored

Where innovation meets collaboration: Live from Manchester’s...

Editor's Picks

Update: MSD confirms $10bn takeover deal for Verona Pharma

AbbVie cuts $1.9bn+ deal with IGI for trispecific antibody

UK authority cracks down on weight-loss drug ads

First malaria drug for newborns and young infants cleared

Medical groups sue RFK Jr over COVID-19 policies

News

Takeda's narcolepsy programme gets back on track

Takeda's narcolepsy programme gets back on track

Takeda will move quickly ahead with regulatory filings for oveporexton as a treatment for narcolepsy after a pair of phase 3 wins.

Market Access

pharmaphorum podcast Episode 178a - Sandra Anderson and Chris Williams, Cencora

The value of a partner, globally and locally

A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face

Pharmaphorum Menu

Digital
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Market Access
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Oncology
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Patients
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
R&D
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Sales & Marketing
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Spotlight on

Sign up for email newsletters and Deep Dive

Subscribe

rss youtube linkedin BlueSky

About us Advertising Contact us

Contribute Cookie Policy Privacy Policy

Terms & Conditions Work for us

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2025, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2025, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company